Study: 40% of Chronic Pain Patients Replace Opioids with Cannabis
Thu / Jan 28th
A recent survey of 525 chronic pain patients found that 40.4% of respondents had replaced their opioid-based medications with medical cannabis.
Opioids are a class of drug that includes synthetics like fentanyl and heroin. Addiction to opioids has been deemed a national epidemic in North America, and cannabis has shown to be a replacement for the often prescribed drug. Read about cannabis news as it relates opioids in the featured articles below.
Thu / Jan 28th
A recent survey of 525 chronic pain patients found that 40.4% of respondents had replaced their opioid-based medications with medical cannabis.
Tue / Dec 22nd
A recent study shows that cannabis can improve treatment outcomes for people in care for opioid addiction.
Thu / Oct 29th
The Massachusetts Supreme Court has ruled that employees who use medical cannabis to treat a work-related injury cannot rely on workers comp insurance to cover it.
Thu / Oct 22nd
Purdue Pharma, the manufacturer of OxyContin, pleaded guilty this week to illegally marketing its deadly and addictive opioid products. As part of its federal settlement, the company faces over $8 billion in penalties.
Fri / Sep 25th
A former NYPD officer is suing the department after being forced into early retirement due to his status as a registered medical cannabis patient. The lawsuit alleges extreme instances of workplace harassment, disability discrimination, and retaliation.
Mon / Jul 20th
New research from the University of California, Irvine has determined that cannabis is a safe and potentially effective treatment for the chronic pain associated with sickle cell disease.
Mon / Jul 13th
The Canadian Association of Chiefs of Police has issued a call for lawmakers to federally decriminalize the low-level possession of all drugs.
Tue / Apr 28th
The FDA has issued warnings to two CBD companies over claims that their products could treat opioid addiction and/or replace pharmaceutical drugs.
Wed / Mar 18th
The UCLA Cannabis Research Initiative has been awarded a $3.9 million grant to investigate whether cannabis terpenes can help reduce the use of opioids in pain treatment.
Mon / Nov 25th
Federal officials at the U.S. Substance Abuse and Mental Health Services Administration have prohibited any federal funds meant to combat opioid addiction from being used on medical cannabis.
Thu / Aug 1st
A new study by the Stanford School of Medicine appears to contradict a commonly cited 2014 study that suggested medical cannabis legalization leads to a reduced rate of opioid overdoses.
Fri / Jun 7th
New Mexico has added six new conditions to the qualifying conditions list for the state’s medical cannabis program. The added conditions include opioid addiction, Alzheimer’s disease, autism, and three neurological disorders.
Mon / May 27th
Under a bill signed into law last week in Colorado, doctors can now recommend medical cannabis to treat any condition for which they might have otherwise prescribed opioids.
Wed / May 22nd
A study in the American Journal of Psychiatry has shown CBD to be effective in reducing the cravings of opioid addicts, with participants citing a two- to three-fold reduction in cravings on average compared to participants who received a placebo.
Tue / Apr 16th
A proposal in Illinois would make the state’s medical cannabis program permanent and add 12 new conditions to the state’s qualifying conditions list.
Wed / Mar 27th
In addition to the new legalization language being considered, the committee also advanced legislation to add opioid use disorder to the state’s medical cannabis qualifying conditions list.
Thu / Jan 24th
New Jersey Gov. Phil Murphy has added opiate addiction as a qualifying condition for medical cannabis, effective immediately. The state has already seen 141 opioid overdose deaths in 2019.
Thu / Jan 10th
Medical experts will study six new conditions to see if there is sufficient evidence for adding them to the state’s medical cannabis program.
Wed / Dec 19th
A study published in the journal JAMA shows that opioids are only slightly more effective than placebo medications at treating… Read More
Wed / Nov 7th
The State Medical Board of Ohio is considering new additions to the list of conditions that qualify patients for medical… Read More
Mon / Sep 17th
Secretary of the New Mexico Department of Health Lynn Gallagher has again declined to add Opioid Use Disorder (OUD) to… Read More
Thu / Sep 6th
A Chicago advertising agency working with medical cannabis company Cresco Labs launched a dramatic medical cannabis campaign in downtown Chicago… Read More
Tue / Aug 28th
A measure written to limit barriers for medical cannabis and provide easier access for patients currently taking prescription opioids will… Read More
Fri / Aug 17th
The Justice Department and Drug Enforcement Agency announced in a news release yesterday the agencies’ new goal for 2019: to reduce production… Read More
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.